ESC 2015: Anticoagulants in atrial fibrillation: Identifying high risk patients

 

Alexander Niessner discusses 'Anticoagulants in atrial fibrillation: Identifying high risk patients' at the 2015 ESC congress in London.

Questions:
1. In atrial fibrillation patients who need treatment with NOACs, how do you identify patients at a high-risk of bleeding?
2. How do you reduce the risk?

Video Category: 

  • Electrophysiology & Arrhythmia
  • Atrial Fibrillation